Expression of p53 in human leukemic cell lines (original) (raw)
Increased expression of p53 protein in human leukemia cells
John Ranyard
Proceedings of the National Academy of Sciences, 1986
View PDFchevron_right
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface
Thierry Soussi
Cancer research, 1993
View PDFchevron_right
P53 content in relation to cell growth and proliferation in murine L1210 leukemia and normal lymphocytes
Albert DeLeo
Leukemia Research, 1986
View PDFchevron_right
Distinct pattern of p53 phosphorylation in human tumors
Toshinari Minamoto
Oncogene, 2001
View PDFchevron_right
Levels of p53 Protein Increase with Maturation in Human Hematopoietic Cells1
Arthur Radin
Cancer Research, 1991
View PDFchevron_right
Levels of p53 protein increase with maturation in human hematopoietic cells
Arthur Radin
PubMed, 1991
View PDFchevron_right
STUDIES ON HUMAN ONCOPROTEIN p53
Toivo Maimets
1991
View PDFchevron_right
Twenty years of p53 research: structural and functional aspects of the p53 protein
Pierre MAY
Oncogene, 1999
View PDFchevron_right
p53 alterations in human cancer: more questions than answers
Thierry Soussi
Oncogene, 2007
View PDFchevron_right
Disruption of p53 in human cancer cells alters the responses to therapeutic agents
Jerry Williams
Journal of Clinical Investigation, 1999
View PDFchevron_right
The p53 protein detected by immunohistochemical staining is not always mutant
Shehla Mohammed
Journal of Cellular Biochemistry, 1993
View PDFchevron_right
Analysis of p53 Antibodies in Patients with Various Cancers Define B-Cell Epitopes of Human p53: Distribution on Primary Structure and Exposure on Protein Surface1
Nicolas Janin
2000
View PDFchevron_right
Ory K, Legros Y, Auguin C, Soussi T.. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J 13: 3496-3504
Thierry Soussi
The EMBO Journal
View PDFchevron_right
Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization
Toivo Maimets, Arnold Kristjuhan
Oncogene, 1998
View PDFchevron_right
p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization
Junhui Bian
View PDFchevron_right
Identification of p53 and Its Isoforms in Human Breast Carcinoma Cells
Vladan Bajic
The Scientific World Journal, 2014
View PDFchevron_right
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors
arie rogel
Molecular and Cellular Biology, 1985
View PDFchevron_right
p53 EXPRESSION IN HAEMATOLOGICAL MALIGNANCIES: RESPONSE TO ALKYLATING AGENT IN THE COMET ASSAY
Dr Behzad Foroutan
2006
View PDFchevron_right
Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein
Thierry Soussi
British journal of cancer, 1994
View PDFchevron_right
p53: From Fundamental Biology to Clinical Applications in Cancer
Alessandro Ottaiano
Biology
View PDFchevron_right
Variation in antigenic determinants of p53 transformation-related protein obtained from various species
Haya Friedman
The Journal of Immunology
View PDFchevron_right
Monoclonal antibody analysis of p53 expression in normal and transformed cells
David S Lane
Journal of virology, 1986
View PDFchevron_right
The amino acid sequence of murine p53 determined from a c-DNA clone
David Goeddel
Virology, 1984
View PDFchevron_right
Multifactorial analysis ofp53 alteration in human cancer: A review
Thierry Soussi
International Journal of Cancer, 1994
View PDFchevron_right
The mutational status of p53 can influence its recognition by human T-cells
Cyrille Cohen
OncoImmunology, 2017
View PDFchevron_right
P53: A Molecular Marker for the Detection of Cancer
Mark Boyd
Expert Opinion on Medical Diagnostics, 2008
View PDFchevron_right
Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines
Kalkunte Srivenugopal
Free Radical Biology and Medicine, 2010
View PDFchevron_right
P53 gene: major mutations in neoplasias and anticancer gene therapy
Lorena Cardoso
Ciência Rural, 2012
View PDFchevron_right
Tumourigenesis associated with the p53 tumour suppressor gene
Arja Tervahauta
British Journal of Cancer, 1993
View PDFchevron_right
[P53 tumor suppressor gene]
Thierry Soussi
Bulletin du cancer
View PDFchevron_right
Soussi T.. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res 60: 1777-1788
Thierry Soussi
Cancer Research
View PDFchevron_right
Life and death by P53
Wen-hwa Lee
BioEssays, 1995
View PDFchevron_right
P53: Its Role in Carcinogenesis And Also A Novel Target for Anti-Cancer Therapy
SUJAN AGRAWAL
IOSR Journal of Dental and Medical Sciences
View PDFchevron_right
Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s
janos Luka
Proceedings of the National Academy of Sciences, 1983
View PDFchevron_right